Total raised
$151.8M
Last: Undisclosed 2022-07
Stage
Acquired
Founded
2013
Headcount
82
HQ
Kefar Sava
Sector
Health Tech & Life Sciences
About
CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize coronary artery disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective, FFR-based decision-making tool for physicians. The companys current focus is specifically on bringing the CathWorks FFRangio System to market in order to provide quick, precise, and objective intraprocedural FFR guidance that will be practical for every case. CathWorks FFRangio System carries the CE mark and received FDA 510(k) clearance in December 2018.
Funding history · 4 rounds · $151.8M total
2022-07
Undisclosed
$75.0M
2021-01
Series D
$30.0M
2019-02
Series C
$30.0M
2017-10
Series B
$15.8M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
decision-makingdigital-healthcare3d-technologymedical-technologiesimagingheart-diseasesnon-invasivediagnosticscardiovascularmedical-devicescardiologydeep-learningdecision-supportpatients3d-imagingartificial-intelligencehealthcarehealthcare-providersalgorithmsx-raycomputer-visionhealthcare-itmedical-productsimage-processingsaasdeep-neural-networksmedical-equipment